臨床前體內影像市場報告：2031 年趨勢、預測與競爭分析

全球臨床前體內影像市場前景光明，在研發和藥物發現市場中充滿機會。預計到 2031 年，全球臨床前體內影像市場規模將達到 15 億美元，2025 年至 2031 年的複合年成長率為 6.2%。該市場的主要促進因素是慢性病盛行率的上升、對非侵入性小動物成像技術的需求的不斷成長，以及對臨床前研究活動的資金增加。

• 在模態類別中，Lucintel 預測超音波系統部分將在預測期內經歷最高的成長。
• 從應用角度來看，由於研究和藥物開發中擴大採用這種模式，研究和開發將繼續成為最大的部分。
• 按地區分類，由於臨床前研究數量的增加以及加拿大政府對研究和創新的津貼增加，預計北美仍將是最大的地區。

臨床前體內影像市場的策略性成長機會

臨床前體內成像領域的特點是跨各種應用的策略性成長機會。由於技術創新和研究活動的不斷增加，成長潛力仍在持續。

• 擴展成像模式：多模態系統的獲取為推進臨床前研究提供了途徑。此策略將有助於詳細研究複雜的細胞現象和疾病病理，為治療方法發展開闢新的途徑。
• 成像過程中成像系統的人工智慧開發：影像分析的另一個具有高成長機會的部分是人工智慧影像分析，它增強了影像資料的使用率。多項研究表明，人工智慧在影像處理中的應用有助於改善監測方法，並最終提高對疾病過程和治療反應的理解。
• 開發具有成本效益的成像解決方案：建構具有成本效益的成像解決方案可滿足對低成本、易於使用的成像技術的需求，尤其是在臨床前研究中。更便宜、更易於存取的系統可能會提高研究能力並使更多機構能夠進行研究。
• 可攜式成像技術的發展：可攜式成像技術的發明透過其靈活性和可用性擴展了研究的可能性。這個可攜式系統可以在小型實驗室和現場工作等各個層面進行體內成像，擴大了臨床前研究的範圍。
• 即時成像的創新：即時成像可以持續評估動態生物過程，開闢新方法並實現進一步發展。這將使我們更容易追蹤細胞功能和疾病的研究進展，從而加強研究和治療方法。

由於通用、可訪問性和技術豐富性的原則，這些成長機會為臨床前體內成像發展提供了巨大的潛力。解決這些問題將有助於推進和改進您的研究。

臨床前體內影像市場促進因素與挑戰

臨床前體內影像市場受到多種因素的影響，包括技術、經濟狀況和監管因素。人們需要了解一些因素，包括幫助市場導航和幫助成長。

推動臨床前體內影像市場發展的因素有：

• 技術進步：成像系統的技術發展，包括即時和多模態成像技術，正在促進臨床前體內成像的擴展。這些變化將提高成像工具的功能、精度和能力，從而實現更深入的研究。
• 對高解析度成像的需求不斷增加：值得注意的是，用於探索病原體引起的複雜生物過程和相互作用的高解析度成像的成長仍然是一個主要驅動力。因此，臨床前測試不再局限於簡單的成像技術，而是提供更深入見解的更先進的成像技術。
• 開發具有成本效益的解決方案：開發經濟實惠的成像解決方案有助於增加這些技術的採用並推動市場成長。價格實惠的成像設備的出現使得在各種環境下（包括資源受限的環境下）採用和推進研究變得更加容易。
• 監管和合規要求：監管問題和安全指南對於市場的成長至關重要。只有符合必要監管標準的成像技術才允許上市，從而提高安全性和效率。

臨床前體內影像市場面臨哪些挑戰？

• 競爭市場動態：臨床前體內影像市場本質上競爭非常激烈。此外，公司需要創新並重新定位其產品在市場上以保持相關性並滿足研究需求。
• 先進技術高成本：大多數先進成像技術往往成本高昂，限制了其廣泛應用，尤其是在較小的研究機構和資源有限的地區。這些成本可能會影響新成像系統的採用和利用。
• 技術複雜性和整合問題：先進影像處理系統的技術複雜性和整合新組件所面臨的不可預見的挑戰很可能決定此類系統在該領域的成功。這意味著技術和操作都必須足夠直覺，以免妨礙現場的成功部署和性能。

這些市場促進因素和挑戰如何與臨床前體內影像市場相互作用？成長由技術發展和需求推動，但市場範圍受到成本、法規和市場競爭的限制。成功克服這些挑戰並同時利用驅動力實現預期的工業成果至關重要。

目錄

第1章執行摘要

第2章全球臨床前體內影像市場：市場動態

• 簡介、背景和分類
• 供應鏈
• 產業驅動力與挑戰

第3章 2019年至2031年市場趨勢及預測分析

• 宏觀經濟趨勢（2019-2024）及預測（2025-2031）
• 全球臨床前體內影像市場趨勢（2019-2024）及預測（2025-2031）
• 全球臨床前體內影像市場（按類型）
  • 光學成像
  • 核子造影
  • MRI顯影劑
  • 超音波顯影劑
  • CT顯影劑
• 全球臨床前體內影像市場（按方式）
  • 光學成像系統
  • 臨床前核子造影系統
  • 微型磁振造影系統
  • 微型超音波系統
  • 微型CT系統
  • 臨床前光聲成像系統
  • 臨床前磁粒子成像（MPI）系統
• 全球臨床前體內影像市場（按應用）
  • 研究與開發
  • 藥物研發
• 全球臨床前體內影像市場（按通路）
  • 製藥公司
  • 生技公司
  • 研究所
  • 其他

第4章2019年至2031年區域市場趨勢與預測分析

• 區域臨床前體內影像市場
• 北美臨床前體內影像市場
• 歐洲臨床前體內影像市場
• 亞太臨床前體內影像市場
• 世界其他地區臨床前體內影像市場

第5章 競爭分析

• 產品系列分析
• 業務整合
• 波特五力分析

第6章 成長機會與策略分析

• 成長機會分析
  • 全球臨床前體內影像市場的成長機會（按類型）
  • 全球臨床前體內影像市場中不同模式的成長機會
  • 全球臨床前體內影像市場的成長機會（按應用）
  • 全球臨床前體內成像市場通路的成長機會
  • 區域臨床前體內影像市場的成長機會
• 全球臨床前體內影像市場的新趨勢
• 戰略分析
  • 新產品開發
  • 全球臨床前體內影像市場容量不斷擴大
  • 全球臨床前體內影像市場的合併、收購與合資企業
  • 認證和許可

第7章主要企業簡介

• Bruker Corporation
• Siemens
• TriFoil Imaging
• PerkinElmer
• VisualSonics

The future of the global preclinical in-vivo imaging market looks promising with opportunities in the research & development and drug discovery markets. The global preclinical in-vivo imaging market is expected to reach an estimated $1.5 billion by 2031 with a CAGR of 6.2% from 2025 to 2031. The major drivers for this market are the growing prevalence of chronic diseases, rising demand for on-invasive small animal imaging techniques, and increasing funding for preclinical research activities.

• Lucintel forecasts that, within the modality category, micro-ultrasound systems segment is expected to witness the highest growth over the forecast period.
• Within the application category, research & development will remain the largest segment due to the increased adoption of modalities for research and drug development.
• In terms of region, North America will remain the largest region due to the increasing volume of preclinical research and growing government funding for research and innovation in Canada.

Gain Valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Preclinical In-Vivo Imaging Market

The sphere of preclinical in-vivo imaging is advancing with a few emerging trends that are overhauling the research and the development activities. The preclinical in-vivo imaging process is characterized by the inclusion of novel technologies or techniques which improve the modalities used.

• Integration of Multimodal Imaging: Interventional and multimodal imaging has led to an increasing trend in imaging systems where PET, MRI and CT techniques are integrated together. Such systems enhance the knowledge regarding the regularity of biological processes, and elucidate pathways that are likely to be disrupted in disease states due to the ability to capture anatomic, functional and molecular processes concurrently.
• Advancement in Contrast Agents and Probes: There is an improved efficiency of in-vivo imaging procedures because of new imaging agents and new types of imaging probes. Preclinical target evaluation and diagnostics may benefit from such innovations because they enable the assessment of the disease process and the efficacy of therapeutic agents on a cellular and molecular level more so than previously possible.
• Utilization of Artificial Intelligence: There has been an increasing adoption of systems that use images and incorporate the application of attention AI that is used for imaging enhancement and interpretation of results. Big data from imaging studies can be analyzed by the machine and produce statistically significant biomarkers where human intelligence is limited significantly improving the quality and pace of research.
• Emergence of Portable Imaging Systems: The portable and compact imaging modalities are maturing and are being utilized in preclinical investigations. Such systems are versatile and allow the possibility of in-vivo imaging in conventional laboratories or field settings without degrading the quality of imaging.
• Advances in Real-Time Imaging: Continuous imaging techniques enhance the prospects of real-time monitoring of biological processes as they occur as opposed to destructive sampling methods. New imaging modalities especially optical and fluorescence have breached the barriers of resolution and temporal limitations to allow time-lapse imaging of cellular events and processes, thus unveiling disease pathology and therapeutic strategies.

These trends are driving significant progress in preclinical in-vivo imaging by praising the level of analysis, facilitating the acquisition of imagery, and getting more work done in quicker times. They are changing the processes by which diseases are studied and new remedies are created by the investigators.

Recent Developments in the Preclinical In-Vivo Imaging Market

There is ever increasing transformation in research capabilities and understanding of biological processes through the recent developments in preclinical in-vivo imaging. Employment of various technologies and improvement of existing methodologies that make research accurate, targeting and within shorter periods are important features of, recent technology advancement.

• Enhanced Multimodal Imaging Systems: Today's multimodal imaging systems involve the combination of previously disparate imaging techniques such as PET, MRI, and CT. This facilitates a multi-faceted approach to the study of biological processes and the acquisition of anatomical, functional and molecular information that will help to resolve some of the challenges posed by preclinical research.
• Advanced Contrast Agents and Probes: The latest imaging contrast agents and imaging probes are increasing the efficacy of in-vivo imaging. These developments allow researchers to demonstrate better targeting of, and distinguish between, various cellular and molecular species, thus improving the study of disease mechanisms and treatment efficiency.
• AI-Driven Image Analysis: The application of artificial intelligence (AI) specifically in image analysis is one of the notable aspects of development. AI algorithms assist in the acquisition and analysis of a large amount of imaging data, allowing gaining of high precision information and expanding the effectiveness to research diagnosis.
• Development of Portable Imaging Technologies: In recent years, there has been a remarkable progress in the use of non-invasive imaging technologies. These systems are efficient due to their flexibility for application in both smaller research laboratories and in the field, thus enhancing the advanced imaging and flexibility to the diverse needs of research.
• Recent Developments in Real-Time Imaging: Here are developments in real-time imaging techniques like highly-resolution optical imaging and fluorescence imaging that aid to continuous observation of biological activities. These techniques give a dynamic view of cellular processes and development of disease, thereby improving the understanding of treatment outcomes and disease processes.

These developments are advancing the field of preclinical in-vivo imaging by technology improvement, enhancing accessibility and expanding research efforts. New tools and methodologies being adopted are facilitating advancement in the understanding of biological systems and the creation of new therapies.

Strategic Growth Opportunities for Preclinical In-Vivo Imaging Market

The sector of preclinical in-vivo imaging is characterized by presence of several strategic growth opportunities in various applications. Growth potentials are persist because of technology innovations and increasing research activity.

• Extension of Modalities for Imaging: The acquisition of multimodal one systems present an avenue of advancing preclinical studies since improving these imaging techniques incorporate more than one. This strategy enhances an in-depth investigation of complicated cellular events and disease pathology, thus offering new avenues in therapy development.
• Development of AI for Imaging System in Imaging Process: Another area of imaging analysis which has a high growth opportunity is AI Imaging Analysis wherein the uses of imaging data are enhanced. Various studies show how AI application on imaging will help improve research processes and even enhance the understanding of disease processes and responses to treatment.
• Development of Cost-Effective Imaging Solutions: The creation of cost-effective imaging solutions meets the demand for imaging technologies that are both low-cost and easy to use, especially in preclinical research. Less expensive systems and greater availability may increase the capacity of research and allow for research to be conducted in a greater number of institutions.
• Growth in Portable Imaging Technologies: The invention of portable imaging technologies extends the possibilities of research through its flexibility and availability. Portable systems permit the performance of in-vivo imaging at various levels such as small labs and fieldwork thus broadening the preclinical scope of investigations.
• Innovations in Real-Time Imaging: Real-time imaging does develop new ways by continuous asses of dynamic biological processes it allows further growth. This makes it easy to track cellular functions and developments in diseases and thus enhance research and therapy methods.

These growth opportunities present amazing potential for the development of preclinical in-vivo imaging in recall of the principles of commonality and, the accessibility and which are richer in technology. Addressing these areas will help in attaining progress and improvement of research.

Preclinical In-Vivo Imaging Market Driver and Challenges

The factors affecting the preclinical in-vivo imaging market are quite a number, technological factors, economic conditions and regulations among others. There are elements which a person should know and they include assistance in the market navigation as well as help in growth.

The factors responsible for driving the preclinical in-vivo imaging market include:

• Technological Advancements: Growth of technologies in regards to the imaging systems such as real time and multimodal imaging technologies is promoting expansion of the preclinical in-vivo imaging. These changes enhance imaging tools' ability, precision, and potential to create research that is more detailed.
• Increasing Demand for High-Resolution Imaging: It is important to note that the growth in high-resolution imaging, used to explore the activities of complex biological processes and pathogen-induced interactions, remains the major factor. Therefore, no more preclinical studies are performed with simple imaging techniques, but with advanced imaging technologies providing deeper insights.
• Development of Cost-Effective Solutions: The development of affordable imaging solutions is a factor spurring growth of the market by expanding the reach of such technologies. The availability of inexpensive imaging equipment makes it easier to incorporate and promote research in all settings including those with resource constraints.
• Regulatory and Compliance Requirements: Regulatory concerns and safety guidelines are crucial for the growth of the market. Only those imaging technologies that meet the necessary regulatory standards are distributed into the market to enhance safety and efficiency, both critical for large-scale use.

Challenges in the preclinical in-vivo imaging market are:

• Competitive Market Dynamics: It is the nature of the market for preclinical in-vivo imaging that makes it worse as it is a very competitive one. Moreover, there is a need for companies to innovate and reposition their products in the market to remain relevant and meet research demands.
• High Costs of Advanced Technologies: Most of these advanced imaging technologies tend to be cost prohibitive which constitutes a hindrance to their scope especially in the case of smaller research institutions or in areas with limited funds. Such costs can influence the uptake and utilization of new imaging systems.
• Technical Complexity and Integration Issues: The technical complexity of advanced imaging systems and unforeseen challenges of incorporating new components can perhaps determine the success of such systems in the field. This means that both the technology and the operation must be intuitive to the extent that they do not inhibit successful deployment and performance in the field.

How these drivers and challenges interact preclinical in vivo imaging market. The growth is supported by the technology development and demand but market scope is limited by cost, regulatory, exchange, and competition. It will be important to overcome these challenges successfully and at the same time take advantage of drivers to reach the desired outcome in the industry.

List of Preclinical In-Vivo Imaging Companies

Companies in the market compete based on product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, preclinical in-vivo imaging companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the preclinical in-vivo imaging companies profiled in this report include-

• Bruker Corporation
• Siemens
• Trifoil Imaging
• PerkinElmer
• Visualsonics

Preclinical In-Vivo Imaging by Segment

The study includes a forecast for the global preclinical in-vivo imaging market by type, modality, application, distribution channel, and region.

Preclinical In-Vivo Imaging Market by Type [Analysis by Value from 2019 to 2031]:

• Optical Imaging
• Nuclear Imaging
• MRI Contrast Agents
• Ultrasound Contrast Agents
• CT Contrast Agents

Preclinical In-Vivo Imaging Market by Modality [Analysis by Value from 2019 to 2031]:

• Optical Imaging Systems
• Preclinical Nuclear Imaging Systems
• Micro-MRI Systems
• Micro-Ultrasound Systems
• Micro-CT Systems
• Preclinical Photoacoustic Imaging Systems
• Preclinical Magnetic Particle Imaging (MPI) Systems

Preclinical In-Vivo Imaging Market by Application [Analysis by Value from 2019 to 2031]:

• Research & Development
• Drug Discovery

Preclinical In-Vivo Imaging Market by Distribution Channel [Analysis by Value from 2019 to 2031]:

• Pharmaceutical Companies
• Biotechnology Companies
• Research Institutes
• Others

Preclinical In-Vivo Imaging Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Preclinical In-Vivo Imaging Market

With recent improvements in preclinical in vivo imaging, remarkable changes have been noted in the areas of drug development, disease modeling, and biological studies. Such developments are improving the processes of observing and assessing living animals to incorporate the findings into the inventions. Important areas like the US, China, Germany, India, and Japan have been handing help with these improvements in terms of technology and more research.

• United States: Within the U.S., there is a growing trend of applying combined imaging systems such as PET, MRI, and CT, which are favorable because the imaging in animal models is more efficient. Furthermore, the introduction of novel imaging agents and imaging molecules is enhancing the in vivo imaging such that much more detail on the bodily operation and the development of the pathology can be obtained.
• China: China is keeping pace with the development of advanced in vivo imaging systems and seeks high-resolution imaging and monitoring without delay. Focus has been made on developing advanced optical imaging systems and imaging software capable of visualizing cellular and molecular nucleocytoplasmic trafficking in response to defined stimuli with high precision. There is also an inclination towards the use of artificial intelligence (AI) in the analysis and interpretation of images.
• Germany: Germany has added additional new inventions for imaging technologies, for example, high-field MRI and sophisticated fluorescence systems. This has been making it possible for researchers to get even better spatial resolution and visualization of more complex biological processes. Germany is also at the forefront of the quest for new imaging systems combining several imaging modalities in one unit to facilitate studies in vivo Yours.
• India: In India, there is a rising focus on making the preclinical in-vivo imaging systems more advanced as well as more cost effective. The other most recent advancements also include the use of economical imaging systems and the creation of imaging facilities in research centers for drug discovery and disease studies. India is also working on increasing the number of international research organizations that will assist researchers in improving imaging technologies.
• Japan: Japan is taking the initiative in advancing the field of imaging with new inventions like the advanced near-infrared fluorescence imaging system and the high resolution optical imaging. With this, more molecular and cellular targets are being targeted and detected in live animals with the help of these cutting-edge technologies. Japanese researchers are now working on the incorporation of imaging technology and other biological research tools to achieve more profound in vivo findings.

Features of the Global Preclinical In-Vivo Imaging Market

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Preclinical in-vivo imaging market size by various segments, such as by type, modality, application, distribution channel, and region in terms of ($B).

Regional Analysis: Preclinical in-vivo imaging market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, modalities, applications, distribution channels, and regions for the preclinical in-vivo imaging market.

Strategic Analysis: This includes M&A, new product development, and the competitive landscape of the preclinical in-vivo imaging market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers the following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the preclinical in-vivo imaging market by type (optical imaging, nuclear imaging, MRI contrast agents, ultrasound contrast agents, and CT contrast agents), modality (optical imaging systems, preclinical nuclear imaging systems, micro-MRI systems, micro-ultrasound systems, micro-CT systems, preclinical photoacoustic imaging systems, and preclinical magnetic particle imaging (MPI) systems), application (research & development and drug discovery), distribution channel (pharmaceutical companies, biotechnology companies, research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Preclinical In-Vivo Imaging Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Preclinical In-Vivo Imaging Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Preclinical In-Vivo Imaging Market by Type
  • 3.3.1: Optical Imaging
  • 3.3.2: Nuclear Imaging
  • 3.3.3: MRI Contrast Agents
  • 3.3.4: Ultrasound Contrast Agents
  • 3.3.5: CT Contrast Agents
• 3.4: Global Preclinical In-Vivo Imaging Market by Modality
  • 3.4.1: Optical Imaging Systems
  • 3.4.2: Preclinical Nuclear Imaging Systems
  • 3.4.3: Micro-MRI Systems
  • 3.4.4: Micro-Ultrasound Systems
  • 3.4.5: Micro-CT Systems
  • 3.4.6: Preclinical Photoacoustic Imaging Systems
  • 3.4.7: Preclinical Magnetic Particle Imaging (MPI) Systems
• 3.5: Global Preclinical In-Vivo Imaging Market by Application
  • 3.5.1: Research & Development
  • 3.5.2: Drug Discovery
• 3.6: Global Preclinical In-Vivo Imaging Market by Distribution Channel
  • 3.6.1: Pharmaceutical Companies
  • 3.6.2: Biotechnology Companies
  • 3.6.3: Research Institutes
  • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Preclinical In-Vivo Imaging Market by Region
• 4.2: North American Preclinical In-Vivo Imaging Market
  • 4.2.1: North American Market by Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-MRI Systems, Micro-Ultrasound Systems, Micro-CT Systems, Preclinical Photoacoustic Imaging Systems, and Preclinical Magnetic Particle Imaging (MPI) Systems
  • 4.2.2: North American Market by Application: Research & Development and Drug Discovery
• 4.3: European Preclinical In-Vivo Imaging Market
  • 4.3.1: European Market by Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-MRI Systems, Micro-Ultrasound Systems, Micro-CT Systems, Preclinical Photoacoustic Imaging Systems, and Preclinical Magnetic Particle Imaging (MPI) Systems
  • 4.3.2: European Market by Application: Research & Development and Drug Discovery
• 4.4: APAC Preclinical In-Vivo Imaging Market
  • 4.4.1: APAC Market by Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-MRI Systems, Micro-Ultrasound Systems, Micro-CT Systems, Preclinical Photoacoustic Imaging Systems, and Preclinical Magnetic Particle Imaging (MPI) Systems
  • 4.4.2: APAC Market by Application: Research & Development and Drug Discovery
• 4.5: ROW Preclinical In-Vivo Imaging Market
  • 4.5.1: ROW Market by Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-MRI Systems, Micro-Ultrasound Systems, Micro-CT Systems, Preclinical Photoacoustic Imaging Systems, and Preclinical Magnetic Particle Imaging (MPI) Systems
  • 4.5.2: ROW Market by Application: Research & Development and Drug Discovery

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Preclinical In-Vivo Imaging Market by Type
  • 6.1.2: Growth Opportunities for the Global Preclinical In-Vivo Imaging Market by Modality
  • 6.1.3: Growth Opportunities for the Global Preclinical In-Vivo Imaging Market by Application
  • 6.1.4: Growth Opportunities for the Global Preclinical In-Vivo Imaging Market by Distribution Channel
  • 6.1.5: Growth Opportunities for the Global Preclinical In-Vivo Imaging Market by Region
• 6.2: Emerging Trends in the Global Preclinical In-Vivo Imaging Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Preclinical In-Vivo Imaging Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Preclinical In-Vivo Imaging Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Bruker Corporation
• 7.2: Siemens
• 7.3: TriFoil Imaging
• 7.4: PerkinElmer
• 7.5: VisualSonics